Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Research Article Free access | 10.1172/JCI115338

Upregulated expression and function of VLA-4 fibronectin receptors on human activated T cells in rheumatoid arthritis.

A Laffón, R García-Vicuña, A Humbría, A A Postigo, A L Corbí, M O de Landázuri, and F Sánchez-Madrid

Seccione de Reumatología, Hospital de la Princesa, Universidad Autónoma de Madrid, Spain.

Find articles by Laffón, A. in: PubMed | Google Scholar

Seccione de Reumatología, Hospital de la Princesa, Universidad Autónoma de Madrid, Spain.

Find articles by García-Vicuña, R. in: PubMed | Google Scholar

Seccione de Reumatología, Hospital de la Princesa, Universidad Autónoma de Madrid, Spain.

Find articles by Humbría, A. in: PubMed | Google Scholar

Seccione de Reumatología, Hospital de la Princesa, Universidad Autónoma de Madrid, Spain.

Find articles by Postigo, A. in: PubMed | Google Scholar

Seccione de Reumatología, Hospital de la Princesa, Universidad Autónoma de Madrid, Spain.

Find articles by Corbí, A. in: PubMed | Google Scholar

Seccione de Reumatología, Hospital de la Princesa, Universidad Autónoma de Madrid, Spain.

Find articles by de Landázuri, M. in: PubMed | Google Scholar

Seccione de Reumatología, Hospital de la Princesa, Universidad Autónoma de Madrid, Spain.

Find articles by Sánchez-Madrid, F. in: PubMed | Google Scholar

Published August 1, 1991 - More info

Published in Volume 88, Issue 2 on August 1, 1991
J Clin Invest. 1991;88(2):546–552. https://doi.org/10.1172/JCI115338.
© 1991 The American Society for Clinical Investigation
Published August 1, 1991 - Version history
View PDF
Abstract

The VLA-4 (CD49d/CD29) integrin is a cell surface receptor involved in the interaction of lymphoid cells with both extracellular matrix (ECM) and endothelial cells. We have investigated the expression and function of VLA-4 fibronectin (FN) receptors on T cells localized in the inflammed synovium of patients with rheumatoid arthritis (RA). A high proportion of T cells in both synovial membrane (SM) and synovial fluid (SF) expressed the activation antigens AIM (CD69) and gp95/85 (Ea2) as well as an increased number of VLA-4 alpha and beta 1 adhesion molecules, as compared with peripheral blood (PB) T cells from the same patients. Furthermore, the majority of these activated SF T cells were able to adhere to a 38-kD FN proteolytic fragment containing the connecting segment-1 (CS-1) specifically through VLA-4 receptors, whereas a significantly lower proportion of PB T cells displayed this capacity. Therefore, our results show that activated T cells selectively localize at sites of tissue injury in RA disease and provide evidence for the in vivo regulation of the expression and function of the VLA-4 integrin. This regulatory mechanism may enable T cells either to facilitate migration or to persist at sites of inflammation.

Images.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 546
page 546
icon of scanned page 547
page 547
icon of scanned page 548
page 548
icon of scanned page 549
page 549
icon of scanned page 550
page 550
icon of scanned page 551
page 551
icon of scanned page 552
page 552
Version history
  • Version 1 (August 1, 1991): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts